Patents by Inventor Berkeley W. Cue

Berkeley W. Cue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4997949
    Abstract: Crystalline 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole dihydrochloride trihydrate having advantageous properties.
    Type: Grant
    Filed: April 20, 1989
    Date of Patent: March 5, 1991
    Assignee: Pfizer Inc.
    Inventors: Douglas J. M. Allen, Berkeley W. Cue
  • Patent number: 4751297
    Abstract: A process for production of a 2-azetidinone-1-oxoacetate of the formula ##STR1## useful as an intermediate for preparation of 2-SR.sup.2 -substituted-2-penem-3-carboxylate andtibacterial agents;R is a conventional hydroxy protecting group, R.sup.1 is certain carboxy protecting groups and ##STR2## and m and n are each 0, 1 or 2; which comprises contacting a corresponding (2-oxo-1-axetidinyl)-N-2-hydroxyacetate ester of the formula ##STR3## with manganese dioxide.
    Type: Grant
    Filed: March 20, 1987
    Date of Patent: June 14, 1988
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Donald K. Pirie
  • Patent number: 4704461
    Abstract: Chiral sorbinil intermediates of the formula ##STR1## wherein R is hydrogen or benzyloxycarbonyl and Y is hydroxy or amino, processes therefor, and processes for the conversion thereof to sorbinil.
    Type: Grant
    Filed: February 14, 1986
    Date of Patent: November 3, 1987
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4632993
    Abstract: 2-Guanidino-4-(2-methyl-4-imidazolyl)thiazole dihydrobromide and a one-pot, high yield process for its preparation from 2-methyl-4(or 5)-acetylimidazole.
    Type: Grant
    Filed: October 11, 1984
    Date of Patent: December 30, 1986
    Assignee: Pfizer Inc.
    Inventor: Berkeley W. Cue, Jr.
  • Patent number: 4632992
    Abstract: Processes and intermediates useful in the preparation of bronchodilator compounds of the formula ##STR1## wherein R is hydrogen, methyl or hydroxymethyl are described. Those compounds wherein R is H or CH.sub.3 have been found to have further utility as intermediates for pirbuterol (wherein R is hydroxymethyl).
    Type: Grant
    Filed: August 16, 1984
    Date of Patent: December 30, 1986
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Stephen S. Massett
  • Patent number: 4620019
    Abstract: Chiral sorbinil intermediates of the formula ##STR1## wherein R is hydrogen or benzyloxycarbonyl and Y is hydroxy or amino, processes therefor, and processes for the conversion thereof to sorbinil.
    Type: Grant
    Filed: August 23, 1984
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4528387
    Abstract: Sorbinil is obtained by cyclization of S-6-fluoro-4-ureidochromane-4-carboxylic acid, which is in turn obtained by resolution of racemic 6-fluoro-4-ureidochroman-4-carboxylic acid via diasteromeric salts with either D-(+)-(1-phenethyl)amine or L-(-)-ephedrine.
    Type: Grant
    Filed: January 9, 1984
    Date of Patent: July 9, 1985
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4477671
    Abstract: Processes and intermediates useful in the preparation of bronchodilator compounds of the formula ##STR1## wherein R is hydrogen, methyl or hydroxymethyl are described. Those compounds wherein R is H or CH.sub.3 have been found to have further utility as intermediates for pirbuterol (wherein R is hydroxymethyl).
    Type: Grant
    Filed: June 2, 1983
    Date of Patent: October 16, 1984
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Stephen S. Massett
  • Patent number: 4451655
    Abstract: A novel process for preparing various 2-substituted-5-aryl-1,2,3,4-tetrahydro-.gamma.-carboline derivatives is provided, which involves (1) quaternizing a corresponding 5-aryl-.gamma.-carboline compound with an appropriate aralkyl halide in the presence of sodium iodide, followed by (2) reduction of the corresponding quaternary carbolinium iodide salt intermediate with an alkali metal hydride to yield the desired final product. The latter compounds are known to be useful as tranquilizing agents, with 2-[4-(p-fluorophenyl)-4-hydroxybutyl]-5-(p-fluorophenyl)-8-fluoro-1,2,3,4- tetrahydro-.gamma.-carboline representing a preferred final product. The aforesaid carbolinium salt intermediates as well as the corresponding 5-aryl-.gamma.-carboline starting materials are all novel compounds.
    Type: Grant
    Filed: May 17, 1982
    Date of Patent: May 29, 1984
    Assignee: Pfizer Inc.
    Inventor: Berkeley W. Cue, Jr.
  • Patent number: 4435578
    Abstract: Sorbinil is obtained by cyclization of S-6-fluoro-4-ureidochromane-4-carboxylic acid, which is in turn obtained by resolution of racemic 6-fluoro-4-ureidochroman-4-carboxylic acid via diasteromeric salts with either D-(+)-(1-phenethyl)amine or L-(-)-ephedrine.
    Type: Grant
    Filed: November 10, 1982
    Date of Patent: March 6, 1984
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4431828
    Abstract: 6-Fluoro-4-chromanone, a sorbinil intermediate, is regenerated from enantiomeric and mixtures of enantiomeric and racemic compounds obtained as major by-products in the synthesis of sorbinil. The regenerated intermediate is useful in the synthesis of additional sorbinil.
    Type: Grant
    Filed: November 10, 1982
    Date of Patent: February 14, 1984
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Philip D. Hammen, Stephen S. Massett
  • Patent number: 4412958
    Abstract: 5-Phenyl-2S-pentanol is synthesized stereospecifically from S ethyl lactate. The method provides easily purified 5-phenyl-2S-pentanol useful in the synthesis of central nervous system active (CNS) agents such as levonantradol.
    Type: Grant
    Filed: August 5, 1982
    Date of Patent: November 1, 1983
    Assignee: Pfizer Inc.
    Inventors: Berkeley W. Cue, Jr., Bernard S. Moore
  • Patent number: 4188325
    Abstract: An aniline is converted to a 3-lower hydrocarbonthiooxindole by processes already known in the art, the product converted to a 3-halo-3-lower hydrocarbonthiooxindole by oxidative halogenation, and the product subjected to hydrolysis to form the desired isatins.
    Type: Grant
    Filed: August 21, 1978
    Date of Patent: February 12, 1980
    Assignee: Regents of University of Minnesota
    Inventors: Paul G. Gassman, Berkeley W. Cue, Jr.
  • Patent number: 4186132
    Abstract: An aniline is converted to a 3-lower hydrocarbonthiooxindole by processes already known in the art, the product converted to a 3-halo-3-lower hydrocarbonthiooxindole by oxidative halogenation, and the product subjected to hydrolysis to form the desired isatins.
    Type: Grant
    Filed: April 15, 1977
    Date of Patent: January 29, 1980
    Assignee: The Regents of the University of Minnesota
    Inventors: Paul G. Gassman, Berkeley W. Cue
  • Patent number: 4100284
    Abstract: The invention relates to novel chemical compounds which have useful antibacterial properties and are also of value in promoting animal growth and improving animal feed efficiency. More specifically, these new chemical compounds are certain sulfonylhydrazones of 1,4-dioxoquinoxaline-2-carboxaldehyde, 4-oxoquinoxaline-2-carboxaldehyde and certain derivatives thereof of formula (I): ##STR1## wherein A is N or N .fwdarw. O; R is a member selected from the group consisting of alkyl having from one to five carbon atoms, trifluoromethyl, phenyl, npahthyl, benzyl, styryl and phenyl substituted by up to two members selected from the group consisting of Cl, F, Br, CH.sub.3, CH.sub.3 O and NO.sub.2 ; R.sup.1 is hydrogen or methyl; R.sup.2 is hydrogen or methyl; R.sup.3 is a 6- or 7-position substituent and is selected from the group H, Cl, CH.sub.3, CH.sub.3 O, SO.sub.2 NH.sub.2, SO.sub.2 NHCH.sub.3 and SO.sub.2 N(CH.sub.3).sub.2 ; R.sup.4 is a 7- or 6-position substituent and is selected from the group H, Cl and CH.
    Type: Grant
    Filed: January 18, 1977
    Date of Patent: July 11, 1978
    Assignee: Pfizer Inc.
    Inventor: Berkeley W. Cue